Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2025 03:00 ET | Source: Cyprumed GmbH

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeuticsCyprumed will be eligible to receive up to $493 million in upfront, development, regulatory...
June 15, 2022 09:00 ET | Source: Roots Analysis

The oral proteins and peptides market is anticipated to grow at a CAGR of 20%, during 2022-2032, claims Roots Analysis

London, June 15, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Oral Proteins and Peptides Market, 2022-2032” report to its list of offerings. Over the past few years,...